Abstract
Standard 4 of the National Service Framework (NSF) for coronary heart disease (CHD) describes population cardiovascular risk screening at primary care level. General practitioners (GPs) are expected to deliver this standard and have their performance monitored as part of their clinical governance programme. Although CHD is an important preventable health problem in the United Kingdom (UK), the effectiveness of primary prevention screening programmes are minimal, even within clinical trial settings, and their cost-effectiveness is not clear. The National Screening Committee has identified clear standards for establishing a screening programme in the UK and the activities described in Standard 4 do not fulfill many of these criteria. Specifically, there are no plans for central organisation and co-ordination, no agreed quality assurance standards, and no uniform system for performance management. The clinical, social, and ethical acceptability of the interventions mandated have not been established, and GPs are left to consider how to redirect resources to achieve the standard. We argue that the benefits of population cardiovascular screening must be established through properly conducted trials and, if a programme is introduced, adequate resources and management structures must first be identified.
Full Text
The Full Text of this article is available as a PDF (59.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Collins R., Peto R., MacMahon S., Hebert P., Fiebach N. H., Eberlein K. A., Godwin J., Qizilbash N., Taylor J. O., Hennekens C. H. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990 Apr 7;335(8693):827–838. doi: 10.1016/0140-6736(90)90944-z. [DOI] [PubMed] [Google Scholar]
- Durrington P. N., Prais H., Bhatnagar D., France M., Crowley V., Khan J., Morgan J. Indications for cholesterol-lowering medication: comparison of risk-assessment methods. Lancet. 1999 Jan 23;353(9149):278–281. doi: 10.1016/s0140-6736(98)04027-6. [DOI] [PubMed] [Google Scholar]
- Hingorani A. D., Vallance P. A simple computer program for guiding management of cardiovascular risk factors and prescribing. BMJ. 1999 Jan 9;318(7176):101–105. doi: 10.1136/bmj.318.7176.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MacMahon S., Rodgers A. The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. Clin Exp Hypertens. 1993 Nov;15(6):967–978. doi: 10.3109/10641969309037085. [DOI] [PubMed] [Google Scholar]
- Man-Son-Hing M., Laupacis A., O'Connor A. M., Biggs J., Drake E., Yetisir E., Hart R. G. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial. JAMA. 1999 Aug 25;282(8):737–743. doi: 10.1001/jama.282.8.737. [DOI] [PubMed] [Google Scholar]
- Marshall T. When people would choose treatment has wide implications. BMJ. 2000 Oct 21;321(7267):1022–1023. [PMC free article] [PubMed] [Google Scholar]
- Protheroe J., Fahey T., Montgomery A. A., Peters T. J. The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis. BMJ. 2000 May 20;320(7246):1380–1384. doi: 10.1136/bmj.320.7246.1380. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Russell M. A., Wilson C., Taylor C., Baker C. D. Effect of general practitioners' advice against smoking. Br Med J. 1979 Jul 28;2(6184):231–235. doi: 10.1136/bmj.2.6184.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Steel N. Thresholds for taking antihypertensive drugs in different professional and lay groups: questionnaire survey. BMJ. 2000 May 27;320(7247):1446–1447. doi: 10.1136/bmj.320.7247.1446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stewart-Brown S., Farmer A. Screening could seriously damage your health. BMJ. 1997 Feb 22;314(7080):533–534. doi: 10.1136/bmj.314.7080.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stott N. Screening for cardiovascular risk in general practice. BMJ. 1994 Jan 29;308(6924):285–286. doi: 10.1136/bmj.308.6924.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wonderling D., Langham S., Buxton M., Normand C., McDermott C. What can be concluded from the Oxcheck and British family heart studies: commentary on cost effectiveness analyses. BMJ. 1996 May 18;312(7041):1274–1278. doi: 10.1136/bmj.312.7041.1274. [DOI] [PMC free article] [PubMed] [Google Scholar]